日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical characteristics and severity of hand, foot, and mouth disease by virus serotype: A prospective hospital-based cohort study

按病毒血清型划分的手足口病临床特征和严重程度:一项基于医院的前瞻性队列研究

Li, Yu; Yang, Junmei; Liang, Lu; Wang, Kai; Turtle, Lance; Li, Peng; Zhou, Yonghong; Shen, Yuanfang; Cui, Peng; Zhou, Chongchen; Qiu, Qi; Guo, Chun; Zeng, Mengyao; Long, Lu; Zhang, Tianchen; Peiris, Malik; Cowling, Benjamin J; Solomon, Tom; Cheng, Yibing; Wu, Peng; Yu, Hongjie

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

CRISPR/Cas9 介导的腺苷 A2A 受体缺失可增强 CAR-T 细胞疗效

Lauren Giuffrida #, Kevin Sek #, Melissa A Henderson, Junyun Lai, Amanda X Y Chen, Deborah Meyran, Kirsten L Todd, Emma V Petley, Sherly Mardiana, Christina Mølck, Gregory D Stewart, Benjamin J Solomon, Ian A Parish, Paul J Neeson, Simon J Harrison, Lev M Kats, Imran G House, Phillip K Darcy, Paul A

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies

RET 溶剂前沿突变介导 RET 驱动的恶性肿瘤对选择性 RET 抑制产生获得性耐药性

Benjamin J Solomon, Lavinia Tan, Jessica J Lin, Stephen Q Wong, Sebastian Hollizeck, Kevin Ebata, Brian B Tuch, Satoshi Yoda, Justin F Gainor, Lecia V Sequist, Geoffrey R Oxnard, Oliver Gautschi, Alexander Drilon, Vivek Subbiah, Christine Khoo, Edward Y Zhu, Michele Nguyen, Dahlia Henry, Kevin R Con

IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors

IL-15预处理增强CAR-T细胞对免疫检查点阻断疗法的反应,从而改善实体瘤的治疗效果

Lauren Giuffrida,Kevin Sek,Melissa A Henderson,Imran G House,Junyun Lai,Amanda X Y Chen,Kirsten L Todd,Emma V Petley,Sherly Mardiana,Izabela Todorovski,Emily Gruber,Madison J Kelly,Benjamin J Solomon,Stephin J Vervoort,Ricky W Johnstone,Ian A Parish,Paul J Neeson,Lev M Kats,Phillip K Darcy,Paul A Beavis

Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma

靶向血小板以改善 KRAS 驱动的肺腺癌的预后

Stephanie R Hyslop, Marliese Alexander, Alesha A Thai, Ariena Kersbergen, Andrew J Kueh, Marco J Herold, Jason Corbin, Pradnya Gangatirkar, Ashley P Ng, Benjamin J Solomon, Warren S Alexander, Kate D Sutherland, Emma C Josefsson

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

Polycomb蛋白的进化保守功能可抑制MHC I类抗原呈递途径,从而使癌细胞逃避免疫攻击。

Marian L Burr ,Christina E Sparbier ,Kah Lok Chan ,Yih-Chih Chan ,Ariena Kersbergen ,Enid Y N Lam ,Elizabeth Azidis-Yates ,Dane Vassiliadis ,Charles C Bell ,Omer Gilan ,Susan Jackson ,Lavinia Tan ,Stephen Q Wong ,Sebastian Hollizeck ,Ewa M Michalak ,Hannah V Siddle ,Michael T McCabe ,Rab K Prinjha ,Glen R Guerra ,Benjamin J Solomon ,Shahneen Sandhu ,Sarah-Jane Dawson ,Paul A Beavis ,Richard W Tothill ,Carleen Cullinane ,Paul J Lehner ,Kate D Sutherland ,Mark A Dawson

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers

ALK 重排肺癌中克唑替尼获得性耐药的机制

Ryohei Katayama, Alice T Shaw, Tahsin M Khan, Mari Mino-Kenudson, Benjamin J Solomon, Balazs Halmos, Nicholas A Jessop, John C Wain, Alan Tien Yeo, Cyril Benes, Lisa Drew, Jamal Carlos Saeh, Katherine Crosby, Lecia V Sequist, A John Iafrate, Jeffrey A Engelman